slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 222,931-222,960
Pages 10,126
Rows per page 30
Component
222,931-222,960 of 303,780
13
The slide displays longitudinal clinical trial data for a drug candidate (Imdusiran) across various dosing regimens (Cohorts E, F, I, J, G, K).Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
14
Clinical trial data showing individual patient responses over time, including two cases of NA retreatment.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
15
Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
16
The slide uses a bulleted list to present key safety outcomes, including lack of serious adverse events and stability of laboratory markers.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
17
Arbutus Biopharma | Investor Presentation Deck | 25 slidesArbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
18
The slide uses a timeline-based process diagram to illustrate the clinical trial randomization and treatment arms.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
19
Shows two parallel trial arms with timelines and patient counts.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
20
The slide details the financial terms of the deal and the scope of the partnership.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
21
Arbutus Biopharma | Investor Presentation Deck | 25 slidesArbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
22
Includes two distinct charts: a bar chart showing IFN-y fold increase and a line chart showing tumor volume reduction over time.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
23
The slide uses a three-column layout to explain the scientific basis and product advantages.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
24
The slide includes a financial summary at the top and a list of clinical trial milestones with completion checkmarks.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · The Ask1 hit
25
Arbutus Biopharma | Investor Presentation Deck | 25 slidesArbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · The Ask1 hit
01
argenx SE | Results Presentation Deck | 14 slidesargenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
02
argenx SE | Results Presentation Deck | 14 slidesargenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
04
argenx SE | Results Presentation Deck | 14 slidesargenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · Key Takeaways1 hit
05
The slide uses a timeline-based clinical trial design framework.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
06
The slide outlines a randomized clinical trial structure.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
07
The slide uses a list format to communicate a roadmap of clinical milestones.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Maturity Curve1 hit
08
argenx SE | Results Presentation Deck | 14 slidesargenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Maturity Curve1 hit
09
The slide uses a 2D matrix-like structure to show expansion vectors.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Maturity Curve1 hit
10
The slide uses a central circular image overlaying a four-quadrant layout of strategic pillars.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · Key TakeawaysLoop · Quick Win Big Bet1 hit
12
The map uses teal dots for VYVGART and a purple dot for VYVGART Hytrulo, though the legend is implicit in the side tables.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
13
The slide combines corporate messaging with a personal patient story to humanize the clinical data.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
14
The slide uses a hub-and-spoke visual metaphor to represent corporate values.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
03
Includes a decorative abstract image on the right side.Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Need1 hit
04
The slide uses a donut chart for volume distribution and a stacked bar chart for ASP comparison.Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Need1 hit
05
The slide uses a map-based visualization to show regional performance, with callout bubbles for percentage change and bar charts for absolute volume.Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Need1 hit
09
The waterfall chart illustrates the bridge between opening and closing cash balances. The table provides a detailed breakdown of debt components and net debt calculation.Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations 1 hit
12
Aston Martin Lagonda | Results Presentation Deck | 18 slidesAston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Action1 hit